Stockreport

UPDATE 1-Novartis hikes 2019 outlook as gene therapy, skin drugs shine [Reuters]

JULIUS BAER GRP UNSP/ADR  (JBAXY) 
NASDAQ:AMEX Investor Relations: juliusbaer.com/group/en/investors
PDF Novartis hikes 2019 outlook as gene therapy, skin drugs shine - Reuters 2 Min Read ZURICH (Reuters) - Novartis ( NOVN.S ) on Tuesday boosted its full-year targets, as [Read more]